Sergey V. Anisimov

"NeuroStem Chip": a novel highly specialized tool to study neural differentiation pathways in human stem cells (2007)

Anisimov, Sergey V, Christophersen, Nicolaj S, Correia, Ana S, Li, Jia-Yi, Brundin, Patrik

Abstract Background Human stem cells are viewed as a possible source of neurons for a cell-based therapy of neurodegenerative disorders, such as Parkinson's disease. Several protocols that generate...

Incidence of "quasi-ditags" in catalogs generated by Serial Analysis of Gene Expression (SAGE) (2004)

Anisimov, Sergey V, Sharov, Alexei A

Abstract Background Serial Analysis of Gene Expression (SAGE) is a functional genomic technique that quantitatively analyzes the cellular transcriptome. The analysis of SAGE libraries relies on the...

Can transcriptome size be estimated from SAGE catalogs? (2003)

Stern, Michael D., Anisimov, Sergey V., Boheler, Kenneth R.

Motivation: SAGE (Serial Analysis of Gene Expression) can be used to estimate the number of unique transcripts in a transcriptome. A simple estimator that corrects for sequencing and sampling errors...

Fibroblast Growth Factor-20 Increases the Yield of Midbrain Dopaminergic Neurons Derived from Human Embryonic Stem Cells

Correia, Ana Sofia, Anisimov, Sergey V., Roybon, Laurent, Li, Jia-Yi, Brundin, Patrik

In the central nervous system, fibroblast growth factor (FGF)-20 has been reported to act preferentially on midbrain dopaminergic neurons. It also promotes the dopaminergic differentiation of stem...

Growth Factors and Feeder Cells Promote Differentiation of Human Embryonic Stem Cells into Dopaminergic Neurons: A Novel Role for Fibroblast Growth Factor-20

Correia, Ana Sofia, Anisimov, Sergey V., Li, Jia-Yi, Brundin, Patrik

Human embryonic stem cells (hESCs) are a potential source of dopaminergic neurons for treatment of patients with Parkinson's disease (PD). Dopaminergic neurons can be derived from hESCs and display a...